MedPath

Florbetaben F-18

Generic Name
Florbetaben F-18
Brand Names
Neuraceq
Drug Type
Small Molecule
Chemical Formula
C21H26FNO3
CAS Number
902143-01-5
Unique Ingredient Identifier
TLA7312TOI

Overview

Florbetaben is a fluorine-18 (18F)-labeled stilbene derivative used for Positron Emission Tomography (PET) imaging of the brain. It is used for the non-invasive detection of the density of ß-amyloid neuritic plaques in the brain of adult patients with cognitive impairment.

Background

Florbetaben is a fluorine-18 (18F)-labeled stilbene derivative used for Positron Emission Tomography (PET) imaging of the brain. It is used for the non-invasive detection of the density of ß-amyloid neuritic plaques in the brain of adult patients with cognitive impairment.

Indication

Florbetaben is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.

Associated Conditions

  • Alzheimer's Disease (AD)
  • Cognitive Deficits

FDA Approved Products

Neuraceq
Manufacturer:Life Molecular Imaging, Ltd
Route:INTRAVENOUS
Strength:135 mCi in 1 mL
Approved: 2022/06/13
NDC:54828-001

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath